MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0006470
Azcad Pharmaceuticals Private Limited
Azcad Pharmaceuticals Private Limited - agriculture in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.36 Cr
▲ 10% YoY
Net profit · FY 2025
₹11.67 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹24.74 Lakh
EBITDA margin 7.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹22.5 Lakh
Issued & subscribed
Open charges
₹13.5 Lakh
Satisfied ₹51.8 Lakh
Company age
12 yrs
Est. 2014
Directors on board
4
As per MCA filings
About Azcad Pharmaceuticals Private Limited
Data last updated:
Azcad Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the agricultural products distribution segment of the agriculture sector. It was incorporated on 02 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2014PTC097172. Its GSTIN is 33AAMCA8448D1ZN (Tamil Nadu).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.5 Lakh. It is led by directors including Kannappanhari Krishnan and Magesh Krishnamoorthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Flat No F – 2 Plot No.21 Sri Ganesh Nagar Korattur, Chennai, Tamil Nadu, India – 600099.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.36 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹11.67 Lakh (net margin 3.5%) and EBITDA of ₹24.74 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 21% over five years.
As per MCA filings, the company has open charges of ₹13.5 Lakh and satisfied charges of ₹51.8 Lakh on record.
Azcad Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0006470). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232TN2014PTC097172
Registration Number 097172
Incorporation Date 02 September 2014
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0006470
Key People
Kannappanhari Krishnan Director Magesh Krishnamoorthy Director Mohana Harikrishnan Director Recognitions & Rankings of Azcad Pharmaceuticals
Contact details
Azcad Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFirst Floor Flat No F – 2 Plot No.21 Sri Ganesh Nagar Korattur, Chennai, Tamil Nadu, India – 600099
- IndustryAgriculture, Agro Retail & Distribution
To see the full contact details of Azcad Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Azcad Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Azcad Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Azcad Pharmaceuticals Private Limited, buy the company report.
Financials of Azcad Pharmaceuticals Private Limited
FY 2025 filings availableAzcad Pharmaceuticals Private Limited reported revenue of ₹3.36 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹3.36 Cr ▲ 10%
Net profit · FY 2025
₹11.67 Lakh margin 3.5%
EBITDA · FY 2025
₹24.74 Lakh margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 30%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 10% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Azcad Pharmaceuticals Private Limited, buy the company report.
Board of directors of Azcad Pharmaceuticals Private Limited
Azcad Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannappanhari Krishnan | Director | 02 Sep 2014 | 12 Years 1 Months | Current |
| Magesh Krishnamoorthy | Director | 02 Sep 2014 | 12 Years 1 Months | Current |
| Mohana Harikrishnan | Director | 30 Sep 2022 | 4 Years 1 Months | Current |
| Usha Magesh | Director | 30 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Azcad Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Protota Pharmaceuticals Private Limited | ₹3.37 Cr (FY 2024) | -18.0% | Mumbai, Maharashtra, India | |||
| Qualchem Healthcare Private Limited | ₹3.36 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Azcad Pharmaceuticals Private Limitedthis company | ₹3.36 Cr (FY 2025) | ₹11.67 Lakh | 3.5% | 10.0% | Chennai, Tamil Nadu, India | |
| Bricent Healthcare Private Limited | ₹3.35 Cr (FY 2025) | 24.0% | Hyderabad, Telangana, India | |||
| Teaspoon Pharmaceuticals (India) Private Limited | ₹3.35 Cr (FY 2025) | 10.0% | Barabanki, Uttar Pradesh, India | |||
| Saffron Therapeutics Private Limited | ₹3.35 Cr (FY 2025) | 82.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Azcad Pharmaceuticals Private Limited, buy the company report.
Auditor
Azcad Pharmaceuticals Private Limited is audited by M S PANDIAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S PANDIAN & CO | FY 2022 | 002550S |
Shareholding
The shareholding of Azcad Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Azcad Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Lakh
Satisfied charges
₹51.8 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2021 | 100462514 | Hdfc Bank Limited | ₹13.5 Lakh | Open | |
| 13 Jan 2022 | 100533701 | Tamilnad Mercantile Bank Limited | ₹1.8 Lakh | Satisfied | |
| 28 Sep 2016 | 100056693 | Tamilnad Mercantile Bank Limited | ₹50 Lakh | Satisfied |
To see the full charge records of Azcad Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Azcad Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Azcad Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Azcad Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAMCA8448D1ZN | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Azcad Pharmaceuticals Private Limited, buy the company report.
Recent activity
Azcad Pharmaceuticals Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Mohana Harikrishnan was appointed as Director on 30 Sep 2022.
AGM
Azcad Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Azcad Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 13 Jan 2022 via Charge ID 100533701 with Tamilnad Mercantile Bank Limited was fully satisfied on 12 Jun 2024.
Charges
A charge registered on 28 Sep 2016 via Charge ID 100056693 with Tamilnad Mercantile Bank Limited was fully satisfied on 21 May 2024.
Charges
A charge with Tamilnad Mercantile Bank Limited of Rs. 50.00 Lakh registered on 28 Sep 2016 with Charge ID 100056693 was modified on 24 May 2023.
Appointed
Mohana Harikrishnan was appointed as Director.
Appointed
Usha Magesh was appointed as Director.
Charges
A charge with Tamilnad Mercantile Bank Limited amounted to Rs. 1.80 Lakh with Charge ID 100533701 was registered on 13 Jan 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.50 Lakh with Charge ID 100462514 was registered on 30 Apr 2021.
Charges
A charge with Tamilnad Mercantile Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100056693 was registered on 28 Sep 2016.
Appointed
Kannappanhari Krishnan was appointed as Director.
Appointed
Magesh Krishnamoorthy was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Azcad Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in agro retail and distribution, within the agriculture industry. It was incorporated on 02 September 2014 (12+ years old) and is registered under CIN U24232TN2014PTC097172.
Azcad Pharmaceuticals has 4 current directors:
- Kannappanhari Krishnan - Director
- Magesh Krishnamoorthy - Director
- Mohana Harikrishnan - Director
- Usha Magesh - Director
The latest financial statements of Azcad Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Azcad Pharmaceuticals is 33AAMCA8448D1ZN, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Azcad Pharmaceuticals is U24232TN2014PTC097172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azcad Pharmaceuticals was incorporated on 02 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Azcad Pharmaceuticals by revenue are Protota Pharmaceuticals Private Limited, Qualchem Healthcare Private Limited, Bricent Healthcare Private Limited, Teaspoon Pharmaceuticals (India) Private Limited, Saffron Therapeutics Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohana Harikrishnan was appointed as Director on 30 Sep 2022. Usha Magesh was appointed as Director on 30 Sep 2022. Kannappanhari Krishnan was appointed as Director on 02 Sep 2014. Azcad Pharmaceuticals has 4 board changes on record in total.
Yes, Azcad Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0006470).
The registered office of Azcad Pharmaceuticals is at First Floor Flat No F – 2 Plot No.21 Sri Ganesh Nagar Korattur, Chennai, Tamil Nadu, India – 600099.
Azcad Pharmaceuticals operates in the agriculture industry, in the agro retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages